메뉴 건너뛰기




Volumn 7, Issue 5, 2001, Pages 1181-1191

The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

ALVAC CARCINOEMBRYONIC ANTIGEN B7 1; ALVAC CEA B7 1; ANTINEOPLASTIC AGENT; B7 ANTIGEN; CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; UNCLASSIFIED DRUG; VIRUS VACCINE;

EID: 0034900416     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (168)

References (48)
  • 12
    • 0032697559 scopus 로고    scopus 로고
    • Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines
    • (1999) Cancer Res. , vol.59 , pp. 5106-5111
    • Hodge, J.1    Schlom, J.2
  • 43
    • 0028289244 scopus 로고
    • Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α
    • (1994) J. Exp. Med. , vol.179 , pp. 1109-1118
    • Sallusto, F.1    Lanzavecchia, A.2
  • 44
    • 0029148878 scopus 로고
    • Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Down-regulation by cytokines and bacterial products
    • (1995) J. Exp. Med. , vol.182 , pp. 389-400
    • Sallusto, F.1    Cella, M.2    Danieli, C.3    Lanzavecchia, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.